• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的比较。

Anatomical versus non-anatomical resection for hepatocellular carcinoma.

机构信息

Department of Surgery, Osaka Medical Centre for Cancer and Cardiovascular Diseases, Osaka, Japan.

出版信息

Br J Surg. 2015 Jun;102(7):776-84. doi: 10.1002/bjs.9815. Epub 2015 Apr 2.

DOI:10.1002/bjs.9815
PMID:25847111
Abstract

BACKGROUND

The optimal surgical resection method in patients with HCC to minimize the risk of local recurrence has not yet been determined. The aim of this study was to compare the prognosis following anatomical versus non-anatomical hepatic resection for hepatocellular carcinoma (HCC).

METHODS

Consecutive patients with HCC without macroscopic vascular invasion, treated by curative resection between 1981 and 2012 at Osaka Medical Centre, were included in this retrospective study. The outcomes of patients selected by propensity score matching were compared.

RESULTS

Some 1102 patients were included, 577 in the anatomical and 525 in the non-anatomical resection group. By propensity score matching, 329 patients were selected into each group. Demographic, preoperative and tumour variables were similar between the propensity score-matched groups, including tumour size, tumour multiplicity, α-fetoprotein level and 15-min indocyanine green retention rate at 15 min. The incidence of microvascular invasion was higher in the matched anatomical resection group (P = 0·048). Stratified analysis of recurrence-free and overall survival rates revealed no statistically significant differences between the two propensity score-matched groups (P = 0·704 and P = 0·381 respectively). There was also no significant difference in the early recurrence rate within 2 years after resection between these groups (P = 0·726). Subset analysis of the early recurrence-free survival rate in patients with and without microvascular invasion revealed no significant differences between the groups (P = 0·312 and P = 0·479 respectively).

CONCLUSION

The resection method had no impact on the risk of HCC recurrence or survival.

摘要

背景

目前尚未确定在肝癌患者中采用何种最佳手术切除方法,以将局部复发风险降至最低。本研究旨在比较解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌(HCC)的预后。

方法

本回顾性研究纳入了 1981 年至 2012 年期间在大阪医疗中心接受根治性切除治疗且无肉眼血管侵犯的 HCC 连续患者。比较了通过倾向评分匹配选择的患者的结果。

结果

共纳入 1102 例患者,其中 577 例行解剖性肝切除术,525 例行非解剖性肝切除术。通过倾向评分匹配,每组选择 329 例患者。匹配后的两组在人口统计学、术前和肿瘤变量方面相似,包括肿瘤大小、肿瘤数量、甲胎蛋白水平和 15 分钟时的吲哚菁绿 15 分钟保留率。在匹配的解剖性肝切除组中,微血管侵犯的发生率较高(P=0.048)。无复发生存率和总生存率的分层分析显示,两组之间无统计学差异(P=0.704 和 P=0.381)。两组之间在切除后 2 年内的早期复发率也无显著差异(P=0.726)。在有无微血管侵犯的患者中进行早期无复发生存率的亚组分析,两组之间无显著差异(P=0.312 和 P=0.479)。

结论

切除方法对 HCC 复发或生存风险无影响。

相似文献

1
Anatomical versus non-anatomical resection for hepatocellular carcinoma.解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的比较。
Br J Surg. 2015 Jun;102(7):776-84. doi: 10.1002/bjs.9815. Epub 2015 Apr 2.
2
Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.无肉眼可见血管侵犯的孤立性肝细胞癌的解剖性切除与非解剖性切除:一项倾向评分匹配分析
J Gastroenterol Hepatol. 2017 Apr;32(4):870-878. doi: 10.1111/jgh.13603.
3
Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria.解剖性肝切除与非解剖性肝切除治疗米兰标准外肝癌。
Br J Surg. 2017 Jan;104(1):118-127. doi: 10.1002/bjs.10311. Epub 2016 Oct 3.
4
Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.倾向评分匹配下腹腔镜与开腹肝切除术治疗肝细胞癌的长期及围手术期结局:一项多机构日本研究
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7. doi: 10.1002/jhbp.276. Epub 2015 Jul 1.
5
A propensity score-matched case-control comparative study of laparoscopic and open liver resection for hepatocellular carcinoma.一项关于腹腔镜与开腹肝切除术治疗肝细胞癌的倾向评分匹配病例对照比较研究。
J Laparoendosc Adv Surg Tech A. 2014 Dec;24(12):872-7. doi: 10.1089/lap.2014.0273.
6
[Surgical treatment of primary liver cancer:a report of 10 966 cases].[原发性肝癌的外科治疗:10966例报告]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
7
Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.血清甲胎蛋白对于预测肝癌切除术后肝癌复发和死亡的特异性是否有用?基于倾向评分和竞争风险分析的检验。
Ann Surg Oncol. 2012 Nov;19(12):3687-96. doi: 10.1245/s10434-012-2416-1. Epub 2012 May 30.
8
Do patients with small solitary hepatocellular carcinomas without macroscopically vascular invasion require anatomic resection? Propensity score analysis.无宏观血管侵犯的小的孤立性肝细胞癌患者是否需要进行解剖性切除?倾向评分分析。
Surgery. 2015 Jan;157(1):27-36. doi: 10.1016/j.surg.2014.06.080.
9
Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.射频消融治疗单个小肝癌可作为肝切除术的替代方法。
Br J Surg. 2016 Jan;103(1):126-35. doi: 10.1002/bjs.9960. Epub 2015 Nov 17.
10
Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.386例连续肝细胞癌患者肝切除术后的生存及复发情况。
J Am Coll Surg. 2000 Oct;191(4):381-8. doi: 10.1016/s1072-7515(00)00700-6.

引用本文的文献

1
Anatomical hepatectomy for achieving textbook outcome for perihilar cholangiocarcinoma treated with curative-intent resection: A multicenter study.旨在通过根治性切除实现肝门部胆管癌教科书式治疗效果的解剖性肝切除术:一项多中心研究。
ILIVER. 2022 Nov 13;1(4):245-251. doi: 10.1016/j.iliver.2022.10.004. eCollection 2022 Dec.
2
Safety and efficacy of laparoscopic portal territory fluorescence navigation-guided anatomical liver resection in hepatocellular carcinoma patients.腹腔镜门静脉区域荧光导航引导下解剖性肝切除在肝细胞癌患者中的安全性和有效性
Surg Endosc. 2025 Apr;39(4):2597-2608. doi: 10.1007/s00464-025-11632-5. Epub 2025 Mar 6.
3
Hepatocellular carcinoma recurrence: Predictors and management.
肝细胞癌复发:预测因素与管理
Liver Res. 2023 Nov 19;7(4):321-332. doi: 10.1016/j.livres.2023.11.004. eCollection 2023 Dec.
4
Recurrence and survival after robotic vs laparoscopic liver resection in very-early to early-stage (BCLC 0-A) hepatocellular carcinoma.极早期至早期(BCLC 0-A期)肝细胞癌机器人手术与腹腔镜肝切除术后的复发及生存情况
Surg Endosc. 2025 Mar;39(3):2116-2128. doi: 10.1007/s00464-025-11553-3. Epub 2025 Feb 4.
5
Long-Term Outcomes of Laparoscopic Anatomical versus Non-Anatomical Liver Resection for Hepatocellular Carcinoma.腹腔镜解剖性与非解剖性肝切除治疗肝细胞癌的长期疗效
J Hepatocell Carcinoma. 2024 Dec 5;11:2413-2425. doi: 10.2147/JHC.S483014. eCollection 2024.
6
Liver Resection for Hepatocellular Carcinoma: Recent Advances.肝细胞癌的肝切除术:最新进展
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102401. doi: 10.1016/j.jceh.2024.102401. Epub 2024 Aug 10.
7
Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study.CNLC Ib期肝细胞癌切除术后大肝切除术对复发的影响:一项倾向评分匹配研究
Int J Surg. 2025 Jan 1;111(1):857-864. doi: 10.1097/JS9.0000000000001879.
8
Impact of anatomical liver resection for hepatocellular carcinoma in preventing early-phase local recurrence after surgery.解剖性肝切除术预防肝细胞癌术后早期局部复发的影响。
J Hepatobiliary Pancreat Sci. 2024 Aug;31(8):513-527. doi: 10.1002/jhbp.12004. Epub 2024 May 27.
9
Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection.钆塞酸二钠增强磁共振成像对单发肝细胞癌患者微血管侵犯的术前预测:肝切除范围手术决策的意义
Liver Cancer. 2023 Jul 7;13(2):181-192. doi: 10.1159/000531786. eCollection 2024 Apr.
10
Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.解剖性与非解剖性肝切除术治疗肝细胞癌:一项欧洲多中心队列研究,纳入肝硬化和非肝硬化患者。
Cancer Med. 2024 Mar;13(5):e6981. doi: 10.1002/cam4.6981.